Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE

Clinical trial NCT05762146 · UNKNOWN

Trial details

NCT number: NCT05762146
Sponsor: Maastricht University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ischemic Stroke, Acute

Start date: 2022-09-05
Primary completion: 2024-02-29
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.